New Markers for Minimal Residual Disease in Acute Lymphoblastic Leukemia
Condition(s):Acute Lymphoblastic LeukemiaLast Updated:August 29, 2017Unknown status
Hide Studies Not Open or Pending
Condition(s):Acute Lymphoblastic LeukemiaLast Updated:August 29, 2017Unknown status
Condition(s):Acute Lymphoblastic LeukemiaLast Updated:March 3, 2010Unknown status
Condition(s):Leukemia, LymphoblasticLast Updated:October 31, 2023Active, not recruiting
Condition(s):Acute Lymphoblastic LeukemiaLast Updated:February 8, 2023Not yet recruiting
Condition(s):Lymphoblastic LeukemiaLast Updated:December 23, 2022Not yet recruiting
Condition(s):Leukemia, Lymphoblastic, AcuteLast Updated:November 8, 2017Unknown status
Condition(s):Leukemia, Acute Lymphoblastic; Precursor B-Cell Lymphoblastic Leukemia; Leukemia, Biphenotypic, Acute; Leukemia, Lymphoblastic, Acute, Philadelphia-Positive; Lymphoblastic LymphomaLast Updated:July 20, 2018Terminated
Condition(s):Lymphoblastic LymphomaLast Updated:October 13, 2011Unknown status
Condition(s):Acute Lymphoblastic LeukemiaLast Updated:January 16, 2019Completed
Condition(s):Acute Lymphoblastic LeukemiaLast Updated:November 14, 2023Recruiting
At TrialBulletin.com, we keep tabs on over 200,000 clinical trials in the US and abroad, using medical data supplied directly by the US National Institutes of Health. Please see the About and Contact page for details.